UBS Knock-Out USD/JPY/ DE000UH9PEN0 /
03.06.2024 16:44:04 | Diff.-0.490 | Geld17:37:27 | Brief17:37:27 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
24.650EUR | -1.95% | 24.550 Geld Vol: 25'000 |
24.580 Brief Vol: 25'000 |
- | 114.3576 JPY | 31.12.2078 | Call |
GlobeNewswire
17:35
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
17:33
Natiivo Hospitality Expands with New South Florida Projects, Hires Yoav Gery as President
GlobeNewswire
17:30
Titan.ium Platform Announces Collaboration with Nokia Improving Security for Global Telecommunicatio...
GlobeNewswire
17:20
New CryptoStaking Strategies Introduced by CryptoHeap to Maximize Investor Returns
GlobeNewswire
17:15
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
GlobeNewswire
17:13
Los Angeles Student Wins NFTE West (Southern California) Youth Entrepreneurship Challenge
GlobeNewswire
17:12
Kirby McInerney LLP Reminds Harbor Diversified, Inc. (HRBR) Investors of Class Action Filing and Enc...
GlobeNewswire
17:11
Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in ...
GlobeNewswire
17:11
Infuse Summer Fun In Your Coffee With Bones Coffee Company’s New, Limited-Edition Summer Flavors
GlobeNewswire
17:02
Cambria Investment Management and Chesapeake Capital Corporation Announces the Launch of the Cambria...
GlobeNewswire
17:00
MidWestOne Financial Group Welcomes Three Key Executive Leaders to the Organization
GlobeNewswire
17:00
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopa...
GlobeNewswire
17:00
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
17:00
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors ...
GlobeNewswire
17:00
CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite